WeChat Mini Program
Old Version Features

Pembrolizumab for Advanced Melanoma: Experience from the Spanish Expanded Access Program

M. González-Cao,A. Arance,J. M. Piulats,I. Marquez-Rodas,J. L. Manzano,A. Berrocal,G. Crespo,D. Rodriguez,E. Perez-Ruiz, M. Berciano,A. Soria,A. G. Castano,E. Espinosa,C. Montagut,L. Alonso,T. Puertolas,C. Aguado, M. A. Royo,R. Blanco, J. F. Rodríguez,E. Muñoz,P. Mut,F. Barron,S. Martin-Algarra, Spanish Melanoma Group

Clinical and Translational Oncology（2017）

Cited 11|Views1
Key words
Expanded access program,Melanoma,Pembrolizumab,Survival,CNS metastases
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined